Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Task Force Created To Promote Transparency, Solicit Public Input

Executive Summary

FDA's formation of an internal Transparency Task Force is a savvy move that allows agency leaders to begin making good on their pledge to enhance openness while having six months before them to decide how exactly that will be done
Advertisement

Related Content

Transparency Initiative In "What Is The Right Thing To Do" Phase - Sharfstein
Transparency Initiative In "What Is The Right Thing To Do" Phase - Sharfstein
FDA transparency comments through Nov. 6
FDA transparency comments through Nov. 6
Advertisement
UsernamePublicRestriction

Register

RS016214

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel